Literature DB >> 20462965

Influence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2).Lewis strain.

Jonathan A Cohen1, Sarah H Lindsey, Nancy T Pirro, K Bridget Brosnihan, Patricia E Gallagher, Mark C Chappell.   

Abstract

The mRen(2).Lewis (mRen2) strain is an ANG II-dependent model of hypertension expressing marked sex differences in blood pressure and tissue injury that also exhibits estrogen and salt sensitivity. Because estrogen and salt influence angiotensinogen (AGT), circulating and renal expression of the protein were assessed in the mRen2 using a sensitive and specific ELISA. Hemizygous female and male mRen2 were placed on normal (1% NaCl, NS)- or high (8% NaCl, HS)-salt diets from 5 to 15 wk of age while a separate NS cohort was ovariectomized (OVX). The OVX mRen2 exhibited higher blood pressure (184 +/- 6 vs. 149 +/- 5 mmHg, n = 6), a 16-fold increase in urinary AGT (uAGT) (0.2 +/- 0.02 vs. 0.01 +/- 0.01 microg x kg(-1) x day(-1), P < 0.01), but no change in proteinuria (PROT). Excretion of AGT was correlated with blood pressure and PROT in the female groups. The HS diet led to higher blood pressure (224 +/- 8 mmHg), a 180-fold increase in uAGT (1.8 +/- 0.2 microg x kg(-1) x day(-1)), and increased PROT (98 +/- 9 vs. 7 +/- 1 mg x kg(-1) x day(-1)). Compared with females, NS males expressed higher excretion of uAGT (3.0 +/- 0.4 microg x kg(-1) x day(-1)) and PROT (32 +/- 5 mg x kg(-1) x day(-1)); both were increased eightfold with HS (uAGT: 23 +/- 3 microg x kg(-1) x day(-1); PROT: 285 +/- 28 mg x kg(-1) x day(-1)) without a change in blood pressure. Although uAGT was markedly higher in the OVX and HS groups, neither renal cortical AGT mRNA or protein expression was increased. Moreover, AGT release in cortical slices was similar for the NS and HS females. We conclude that the increase in uAGT with estrogen depletion or HS likely may be a biomarker for glomerular damage reflecting filtration of the circulating protein in the mRen2.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20462965      PMCID: PMC2904164          DOI: 10.1152/ajprenal.00138.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  29 in total

1.  Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat.

Authors:  Mark C Chappell; Patricia E Gallagher; David B Averill; Carlos M Ferrario; K Bridget Brosnihan
Journal:  Hypertension       Date:  2003-07-21       Impact factor: 10.190

Review 2.  Regulation of intrarenal angiotensin II in hypertension.

Authors:  L Gabriel Navar; Lisa M Harrison-Bernard; Akira Nishiyama; Hiroyuki Kobori
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

3.  Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women.

Authors:  D M Herrington; B E Pusser; W A Riley; T Y Thuren; K B Brosnihan; E A Brinton; D B MacLean
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

Review 4.  Renin angiotensin system and gender differences in the cardiovascular system.

Authors:  Marcus Fischer; Andrea Baessler; Heribert Schunkert
Journal:  Cardiovasc Res       Date:  2002-02-15       Impact factor: 10.787

5.  Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice.

Authors:  R L Davisson; Y Ding; D E Stec; J F Catterall; C D Sigmund
Journal:  Physiol Genomics       Date:  1999-07-15       Impact factor: 3.107

6.  Urinary angiotensinogen accurately reflects intrarenal Renin-Angiotensin system activity.

Authors:  Maki Urushihara; Shuji Kondo; Shoji Kagami; Hiroyuki Kobori
Journal:  Am J Nephrol       Date:  2010-02-15       Impact factor: 3.754

7.  Androgen regulation of rat renal angiotensinogen messenger RNA expression.

Authors:  K E Ellison; J R Ingelfinger; M Pivor; V J Dzau
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

8.  Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats.

Authors:  Licy L Yanes; Julio C Sartori-Valinotti; Radu Iliescu; Damian G Romero; Lorraine C Racusen; Huimin Zhang; Jane F Reckelhoff
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-11

9.  Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension.

Authors:  Fang Liu; Chih-Chang Wei; Shyh-Jong Wu; Isabelle Chenier; Shao-Ling Zhang; Janos G Filep; Julie R Ingelfinger; John S D Chan
Journal:  Kidney Int       Date:  2008-10-15       Impact factor: 10.612

10.  Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene.

Authors:  Ovidiu Baltatu; Cécile Cayla; Radu Iliescu; Dmitrii Andreev; Cynthia Jordan; Michael Bader
Journal:  J Am Soc Nephrol       Date:  2002-11       Impact factor: 10.121

View more
  20 in total

1.  Amelioration of renal injury and oxidative stress by the nNOS inhibitor L-VNIO in the salt-sensitive mRen2.Lewis congenic rat.

Authors:  Liliya M Yamaleyeva; Sarah H Lindsey; Jasmina Varagic; Li Li Zhang; Patricia E Gallagher; Alex F Chen; Mark C Chappell
Journal:  J Cardiovasc Pharmacol       Date:  2012-06       Impact factor: 3.105

2.  Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide.

Authors:  Tanya M Gwathmey; Brian M Westwood; Nancy T Pirro; Lijun Tang; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-01

3.  Urinary angiotensinogen increases in the absence of overt renal injury in high fat diet-induced type 2 diabetic mice.

Authors:  Virginia Reverte; Venkateswara R Gogulamudi; Carla B Rosales; Diego C Musial; Sabrina R Gonsalez; Alberto J Parra-Vitela; Michelle Galeas-Pena; Venkata N Sure; Bruna Visniauskas; Sarah H Lindsey; Prasad V G Katakam; Minolfa C Prieto
Journal:  J Diabetes Complications       Date:  2019-10-05       Impact factor: 2.852

4.  Hypersensitivity to acute ANG II in female growth-restricted offspring is exacerbated by ovariectomy.

Authors:  Norma B Ojeda; Suttira Intapad; Thomas P Royals; Joshua T Black; John Henry Dasinger; F Lee Tull; Barbara T Alexander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

5.  Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.

Authors:  Liliya M Yamaleyeva; Shea Gilliam-Davis; Igor Almeida; K Bridget Brosnihan; Sarah H Lindsey; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-29

6.  Salt Loading Promotes Kidney Injury via Fibrosis in Young Female Ren2 Rats.

Authors:  Javad Habibi; Melvin R Hayden; Carlos M Ferrario; James R Sowers; Adam T Whaley-Connell
Journal:  Cardiorenal Med       Date:  2014-03-14       Impact factor: 2.041

Review 7.  Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?

Authors:  Mark C Chappell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

8.  Salt-induced renal injury in SHRs is mediated by AT1 receptor activation.

Authors:  Dinko Susic; Edward D Frohlich; Hiroyuki Kobori; Weijian Shao; Dale Seth; L Gabriel Navar
Journal:  J Hypertens       Date:  2011-04       Impact factor: 4.844

9.  Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.

Authors:  Norihito Moniwa; Jasmina Varagic; Sarfaraz Ahmad; Jessica L VonCannon; Stephen W Simington; Hao Wang; Leanne Groban; K Bridget Brosnihan; Sayaka Nagata; Johji Kato; Kazuo Kitamura; R Ariel Gomez; Maria L Sequeira Lopez; Carlos M Ferrario
Journal:  Hypertension       Date:  2012-12-10       Impact factor: 10.190

Review 10.  Evidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen.

Authors:  Sarah H Lindsey; Mark C Chappell
Journal:  Gend Med       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.